Plerixafor NDC 70710-1208

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1208Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1208Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-1208-1	70710120801	1 VIAL, SINGLE-USE in 1 CARTON (70710-1208-1) / 1.2 mL in 1 VIAL, SINGLE-USEMarketed from Jul 28, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Plerixafor
Generic name (nonproprietary): plerixafor
Active ingredients: Plerixafor — 24 mg/1.2mL
Dosage form: Injection
Route: Subcutaneous
Labeler: Zydus Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208980
Marketing start: Jul 28, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Increased Hematopoietic Stem Cell Mobilization (Physiologic effect)
Identifiers: Product ID 70710-1208_6eded16b-f43d-4984-bd7c-33ca6d5e3195SPL ID 6eded16b-f43d-4984-bd7c-33ca6d5e3195SPL set ID a0a058f9-1618-4853-9b8a-e9768ee86b39RxCUI 828700UNII S915P5499N
Pharmacologic class: Hematopoietic Stem Cell Mobilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470710120801 followed by a unit qualifier and the quantity

Package 70710-1208-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 6, 2024.

Indications (excerpt from the label)

Plerixafor injection, a hematopoietic stem cell mobilizer, is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma or multiple myeloma. ( 1 ) Plerixafor injection is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 208980

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208980
Product	Strength	Form · route	Labeler	Product NDC
Plerixafor	Plerixafor 24 mg/1.2mL	InjectionSubcutaneous	Zydus Lifesciences Limited	70771-1776